The Impact of Diabetes Mellitus on Prognosis of Early Breast Cancer in Asia
- 1 April 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 17 (4) , 485-491
Abstract
Background.: Diabetes mellitus (DM) has been implicated in influencing the survival duration of patients with breast cancer. However, less is known about the impact of DM and other comorbidities on the breast cancer–specific survival (BCS) and overall survival (OS) outcomes of Asian patients with early-stage breast cancer. Patients and Methods.: The characteristics of female patients with newly diagnosed, early-stage breast cancer were collected from the Taiwan Cancer Registry database for 2003–2004. DM status and other comorbidities were retrieved from Taiwan's National Health Insurance database. The BCS and OS times of patients according to DM status were estimated via the Kaplan–Meier method. Cox's proportional hazard model was used to estimate adjusted hazard ratios (HRs) for the effects of DM, comorbidities, and other risk factors on mortality. Results.: In total, 4,390 patients were identified and 341 (7.7%) presented with DM. The 5-year BCS and OS rates were significantly greater in DM patients than in non-DM patients (BCS, 85% versus 91%; OS, 79% versus 90%). Furthermore, after adjusting for clinicopathologic variables and comorbidities, DM remained an independent predictor of shorter BCS (adjusted HR, 1.53) and OS (adjusted HR, 1.71) times. Subgroup analyses also demonstrated a consistent prognostic influence of DM across different groups. Conclusion.: In Asian patients with early-stage breast cancer, DM is an independent predictor of lower BCS and OS rates, even after adjusting for other comorbidities. The integration of DM care as part of the continuum of care for early-stage breast cancer should be emphasized.Keywords
Funding Information
- Bureau of National Health Insurance
- Department of Health, Taiwan (DOH96-NH-1003)
- Science and Technology Unit
- Department of Health, Taiwan (DOH99-TD-B-111-001, DOH100-TD-B-111-001)
This publication has 34 references indexed in Scilit:
- Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-analysisJNCI: Journal of the National Cancer Institute, 2011
- The Influence of Comorbidities on Overall Survival Among Older Women Diagnosed With Breast CancerJNCI: Journal of the National Cancer Institute, 2011
- Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trialBritish Journal of Cancer, 2011
- Clinically Defined Type 2 Diabetes Mellitus and Prognosis in Early-Stage Breast CancerJournal of Clinical Oncology, 2011
- Diabetes Mellitus and Breast Cancer Outcomes: A Systematic Review and Meta-AnalysisJournal of Clinical Oncology, 2011
- Secular trends in breast cancer mortality in five East Asian populations: Hong Kong, Japan, Korea, Singapore and TaiwanCancer Science, 2010
- Medical comorbidities predict mortality in women with a history of early stage breast cancerBreast Cancer Research and Treatment, 2010
- Prognostic Effects of 25-Hydroxyvitamin D Levels in Early Breast CancerJournal of Clinical Oncology, 2009
- Impact of Diabetes Mellitus on Complications and Outcomes of Adjuvant Chemotherapy in Older Patients With Breast CancerJournal of Clinical Oncology, 2009
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992